Thank you, you are now logged in. x
Long-term ticagrelor benefits MI patients

Long-term ticagrelor benefits MI patients

International trial supports extension of dual antiplatelet therapy beyond one year

Study highlights STEMI treatment gender gap

Study highlights STEMI treatment gender gap

An “unfair” bias results in avoidable deaths, say Australian researchers

Endovascular therapy benefits ‘unequivocal’: study

Endovascular therapy benefits ‘unequivocal’: study

Melbourne researchers stop randomised trial of mechanical thrombectomy for ischaemic stroke early due to efficacy

Multivascular PCI may be the way to go in STEMI

Multivascular PCI may be the way to go in STEMI

Finding could change current practice if backed up with further randomised trials

Ezetimibe data confirms CHD benefits for high-risk patients

Ezetimibe data confirms CHD benefits for high-risk patients

The medication cuts risk of coronary events when prescribed in combination with statin therapy

Latest News

view more

Opinion

WCC blog: secondary prevention is the low hanging fruit

One of the most interesting presentations at the World Congress of Cardiology in Melbourne this week was a talk by Professor Philip Aylward of Adelaide on how far we have come in the treatment of ACS.

CSANZ 2013 blog: For the ticker, timing is everything

While it’s great to attend a conference like CSANZ, the sheer amount of new and interesting information can be almost too much of a good thing.

view more

Cardiology Update on Twitter

­
Advertisement
Advertisement
Advertisement